RJ
Insider
Roger Jeffs
DirectorRoger Jeffs (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $4.6M of LQDA (75,000 sh across 3 lots, as filed), executed May 21.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$31.7M
shares × price, as filed
Last traded
Jul 13
Filed Jul 14
Median ADV $143.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $46.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
13 filings
Sector per market data · by filing · past 12 months
Most traded names
LQDA
Liquidia Corporation
LQDA · 0 buys · 18 sells
18 filings
AXSMRecent filings
LQDASALE
Liquidia Corporation
View filing →
$2.1M53,300 sh across 3 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET LQDASALE Liquidia Corporation View filing → $2.1M
54,177 sh across 2 lots
Exec Apr 10
Filed Apr 14 · 5:30 PM ET LQDASALE Liquidia Corporation View filing → $1.0M
25,000 sh × $40.12
Exec Apr 9
Filed Apr 13 · 5:30 PM ET LQDASALE Liquidia Corporation View filing → $2.5M
66,610 sh × $37.43
Exec Jan 12
Filed Jan 13 · 5:30 PM ET LQDASALE Liquidia Corporation View filing → $474K
20,261 sh × $23.41
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $1.7M
13,464 sh × $123.68
Exec Sep 2 2025
Filed Sep 2 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $7.3M
60,000 sh across 3 lots
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $4.4M
36,694 sh across 2 lots
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET More filings →